PHGDH as a mechanism for resistance in metabolically-driven cancers.
PHGDH as a mechanism for resistance in metabolically-driven cancers.
复制标题
DOI:
10.20517/cdr.2020.46
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Van Tine BA
中科院分区:
文献类型:
--
作者:
Rathore R;Schutt CR;Van Tine BA
At the forefront of cancer research is the rapidly evolving understanding of metabolic reprogramming within cancer cells. The expeditious adaptation to metabolic inhibition allows cells to evolve and acquire resistance to targeted treatments, which makes therapeutic exploitation complex but achievable. 3-phosphoglycerate dehydrogenase (PHGDH) is the rate-limiting enzyme of de novo serine biosynthesis and is highly expressed in a variety of cancers, including breast cancer, melanoma, and Ewing’s sarcoma. This review will investigate the role of PHGDH in normal biological processes, leading to the role of PHGDH in the progression of cancer. With an understanding of the molecular mechanisms by which PHGDH expression advances cancer growth, we will highlight the known mechanisms of resistance to cancer therapeutics facilitated by PHGDH biology and identify avenues for combatting PHGDH-driven resistance with inhibitors of PHGDH to allow for the development of effective metabolic therapies.
登录
查看更多内容
影响因子:
11.4
作者:
Chng, W-J;Huang, G. F.;Chung, T. H.;Ng, S. B.;Gonzalez-Paz, N.;Troska-Price, T.;Mulligan, G.;Chesi, M.;Bergsagel, P. L.;Fonseca, R.
通讯作者:
Fonseca, R.
影响因子:
3.8
作者:
Heppt MV;Siepmann T;Engel J;Schubert-Fritschle G;Eckel R;Mirlach L;Kirchner T;Jung A;Gesierich A;Ruzicka T;Flaig MJ;Berking C
通讯作者:
Berking C
影响因子:
5.6
作者:
Corbin JM;Ruiz-Echevarría MJ
通讯作者:
Ruiz-Echevarría MJ
影响因子:
9.8
作者:
Acuna-Hidalgo, Rocio;Schanze, Denny;Zenker, Martin
通讯作者:
Zenker, Martin
影响因子:
--
作者:
Busuttil RA;Zapparoli GV;Haupt S;Fennell C;Wong SQ;Pang JM;Takeno EA;Mitchell C;Di Costanzo N;Fox S;Haupt Y;Dobrovic A;Boussioutas A
通讯作者:
Boussioutas A